AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureNamed GroupsHealth CareGeographicals
ClozapineAntipsychotic AgentsRisperidoneSchizophreniaDibenzothiazepinesHaloperidolBenzodiazepinesPsychotic DisordersSchizophrenic PsychologyOff-Label UseFluphenazineThioridazineNeuroleptic Malignant SyndromeChlorpromazineMedication AdherencePirenzepineHyperprolactinemiaDyskinesia, Drug-InducedReceptors, Dopamine D2Psychiatric Status Rating ScalesPolypharmacyPsychotropic DrugsDopamine AntagonistsAkathisia, Drug-InducedMedication ErrorsBrief Psychiatric Rating ScalePsychomotor AgitationQuinolonesSchizophrenia, ParanoidHallucinationsDrug PrescriptionsTreatment OutcomeBipolar DisorderDibenzothiepinsDrug UtilizationPiperazinesDrug TherapyCatalepsySexual Dysfunctions, PsychologicalDrug SubstitutionMedicaidDrug LabelingBasal Ganglia DiseasesDrug Therapy, CombinationPatient DropoutsPatient ComplianceMental DisordersWeight GainNursing HomesOutpatientsPhysician's Practice PatternsDose-Response Relationship, DrugPhencyclidineUnited StatesLong-Term CareTrifluoperazinePrefrontal CortexDelayed-Action PreparationsDouble-Blind MethodSeverity of Illness IndexRemedial TeachingPerphenazineDrug Utilization ReviewThiazolesPsychoses, Substance-InducedReceptors, DopamineReceptor, Serotonin, 5-HT2ADrug Administration ScheduleStartle ReactionMedication ReconciliationMedication SystemsSerotonin AntagonistsRetrospective StudiesTime FactorsMedication Systems, HospitalCognition DisordersBrainCognitive TherapyAnalysis of VarianceReceptors, SerotoninApomorphineRandomized Controlled Trials as TopicDopamine AgonistsSulpirideCross-Sectional StudiesFollow-Up StudiesNeuropsychological TestsLoxapineSocial AdjustmentHospitalizationRisk FactorsReceptors, Dopamine D3Receptors, Serotonin, 5-HT2Mood DisordersCohort StudiesReceptors, Dopamine D4Serotonin Receptor AgonistsNeurotensinProspective StudiesRaclopride